Asia Pacific faces unique challenges in the area of rheumatic
diseases management. The region is incredibly diverse, with wide cultural
differences in each country and varying stages of development and growth.
To meet these challenges, ARISE with APLAR was established as a
partnership between APLAR and Janssen Asia Pacific at the 15th APLAR Congress in
Jordan in September, 2012.
As a collaborative force and pioneering platform for medical
education, ARISE with APLAR aims to overcome these challenges by delivering
state-of-the-art care and increasing public awareness and understanding of
This partnership combines APLAR’s vast knowledge and increasing
influence as the largest rheumatology association in the Asia Pacific region
with Janssen’s global leadership in Immunology.
At the launch ceremony, then APLAR President Prof. Rohini Handa said
that this strategic collaboration represented one of the “greatest achievements”
of his two-year term.
“Addressing unmet medical needs in rheumatology is a major challenge
for APLAR, and we are delighted to make a bigger difference by partnering with
one of the world’s leaders in Immunology”, said 2012-2013APLAR President Prof.
Zhanguo Li. “The combination of our respective strengths will allow us to do
more for our patients,” he added.
Immunology Medical Affairs Lead for Janssen Asia Pacific, Dr Malcolm
Handel stated, “We aim to share our knowledge and bring resources to the vast
number of rheumatologists in our region directly to their
doorsteps.”The ARISE program continues to evolve and develop and reached an
important milestone in 2014 with the launch of the ARISE with APLAR Global